PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoVac) in the UK

Y. Jiang; A. Gauthier; S.T. Keeping; S.M. Carroll

doi:10.1016/j.jval.2012.08.1131

PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoVac) in the UK

Value in Health ◽

10.1016/j.jval.2012.08.1131 ◽

2012 ◽

Vol 15 (7) ◽

pp. A396-A397 ◽

Cited By ~ 1

Author(s):

Y. Jiang ◽

A. Gauthier ◽

S.T. Keeping ◽

S.M. Carroll

Keyword(s):

At Risk ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

The Elderly ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

The Uk ◽

The Cost

Get full-text (via PubEx)

Cost–effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1586/14737167.2014.950232 ◽

2014 ◽

Vol 14 (6) ◽

pp. 913-927 ◽

Cited By ~ 16

Author(s):

Yiling Jiang ◽

Aline Gauthier ◽

Sam Keeping ◽

Stuart Carroll

Keyword(s):

At Risk ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

The Elderly ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

The Uk

Get full-text (via PubEx)

A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1586/14737167.2014.953932 ◽

2014 ◽

Vol 14 (6) ◽

pp. 901-911 ◽

Cited By ~ 8

Author(s):

Yiling Jiang ◽

Aline Gauthier ◽

Sam Keeping ◽

Stuart Carroll

Keyword(s):

Public Health ◽

At Risk ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Impact Analysis ◽

Budget Impact ◽

The Elderly ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

The Uk

Get full-text (via PubEx)

PIN19 A Budget Impact (BI) Analysis of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to No Vaccination (NoVac) or 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in the UK

Value in Health ◽

10.1016/j.jval.2012.08.1086 ◽

2012 ◽

Vol 15 (7) ◽

pp. A388 ◽

Cited By ~ 1

Author(s):

Y. Jiang ◽

A. Gauthier ◽

S.T. Keeping ◽

S.M. Carroll

Keyword(s):

At Risk ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Budget Impact ◽

The Elderly ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

The Uk

Get full-text (via PubEx)

The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults

PLoS ONE ◽

10.1371/journal.pone.0227945 ◽

2020 ◽

Vol 15 (1) ◽

pp. e0227945

Author(s):

Charles Feldman ◽

Sipho K. Dlamini ◽

Shabir A. Madhi ◽

Susan Meiring ◽

Anne von Gottberg ◽

...

Keyword(s):

Cost Effectiveness ◽

South African ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

The Cost

Get full-text (via PubEx)

A Cost-Effectiveness Analysis of Vaccinating The Elderly with The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared To No Vaccination, The 13-Valent Pneumococcal Conjugate Vaccine (Pcv13), or Pcv13 Followed by Ppv23 in Brazil

Value in Health ◽

10.1016/j.jval.2017.08.2909 ◽

2017 ◽

Vol 20 (9) ◽

pp. A930 ◽

Cited By ~ 1

Author(s):

Y Jiang ◽

X Yang ◽

T Petigara ◽

L Chabrol Haas ◽

J Graham

Keyword(s):

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

The Elderly ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

Get full-text (via PubEx)

CE1 The Cost-Effectiveness Analysis of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Taiwan

Value in Health ◽

10.1016/j.jval.2012.08.003 ◽

2012 ◽

Vol 15 (7) ◽

pp. A602 ◽

Cited By ~ 1

Author(s):

D.B.C. Wu ◽

C.J. Chang ◽

L. Chien ◽

H.C.H. Fang ◽

C.S. Roberts

Keyword(s):

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis ◽

The Cost

Get full-text (via PubEx)

PIN17 Modelling Budget Impact (BI) of Vaccinating At-Risk Adults and the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Germany

Value in Health ◽

10.1016/j.jval.2011.08.205 ◽

2011 ◽

Vol 14 (7) ◽

pp. A268 ◽

Cited By ~ 1

Author(s):

Y. Jiang ◽

A. Gauthier ◽

L. Annemans ◽

M. van der Linden ◽

L. Nicolas-Spony ◽

...

Keyword(s):

At Risk ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Budget Impact ◽

The Elderly ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine

Get full-text (via PubEx)

VACCINATING OLDER ADULTS IN JAPAN WITH 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) OR NO VACCINATION (NOVAC): A COST-EFFECTIVENESS ANALYSIS

10.26226/morressier.5731f0d6d462b8029237fcb3 ◽

2016 ◽

Author(s):

Yiling Jiang

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

Get full-text (via PubEx)

VACCINATING OLDER ADULTS IN KOREA WITH 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) COMPARED TO 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) OR NO VACCINATION (NOVAC): A COST-EFFECTIVENESS ANALYSIS

10.26226/morressier.5731f0d6d462b8029237fcb8 ◽

2016 ◽

Cited By ~ 1

Author(s):

Yiling Jiang

Keyword(s):

Older Adults ◽

Cost Effectiveness ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Cost Effectiveness Analysis ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine ◽

Effectiveness Analysis

Get full-text (via PubEx)

Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan

PLoS ONE ◽

10.1371/journal.pone.0139140 ◽

2015 ◽

Vol 10 (10) ◽

pp. e0139140 ◽

Cited By ~ 17

Author(s):

Shu-ling Hoshi ◽

Masahide Kondo ◽

Ichiro Okubo

Keyword(s):

Single Dose ◽

Economic Evaluation ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Immunisation Programme ◽

The Elderly ◽

Polysaccharide Vaccine ◽

Pneumococcal Polysaccharide Vaccine

Get full-text (via PubEx)